Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NantKwest and ProMab partner to develop NK cell therapies

pharmaceutical-technologyMarch 06, 2019

Tag: immunotherapy , NantKwest , ProMab

PharmaSources Customer Service